Premier NGS in IMGGE

Sophisticated research equipment, the Next-generation sequencing System (MiSeq, Illumina) has come to IMGGE. It will enable implementation of cutting-edge methodology for the study of molecular markers of rare diseases in the IMGGE.

1 DSC04455

The first run on MiSeq Illumina has been successfully completed in IMGGE. Samples of childhood and adult acute myeloid and acute lymphoid leukemia, as well as lymphoma samples have been analyzed using TruSeq Amplicon – Cancer Panel (TSACP).




To be continued…

Leave a Reply

Your email address will not be published. Required fields are marked *